Cargando…

EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169649/
http://dx.doi.org/10.1007/s40278-020-77007-4
_version_ 1783523803181088768
collection PubMed
description
format Online
Article
Text
id pubmed-7169649
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71696492020-04-21 EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic Reactions Weekly News Item Springer International Publishing 2020-04-11 2020 /pmc/articles/PMC7169649/ http://dx.doi.org/10.1007/s40278-020-77007-4 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic
title EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic
title_full EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic
title_fullStr EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic
title_full_unstemmed EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic
title_short EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic
title_sort ema: continue use of ace inhibitors, sartans during covid-19 pandemic
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169649/
http://dx.doi.org/10.1007/s40278-020-77007-4